Chemotherapy for advanced transitional cell carcinoma of the urothelium: Cisplatin or carboplatin?

被引：4

作者：

Culine, Stephane ^{[1
]}

机构：

[1] CRIN, Dept Med Oncol, F-34298 Montpellier 5, France

来源：

EUROPEAN UROLOGY | 2007年 / 52卷 / 01期

关键词：

D O I：

10.1016/j.eururo.2007.01.017

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：9 / 10

页数：2

共 10 条

[1]

Bellmunt J, 1997, CANCER-AM CANCER SOC, V80, P1966, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1966::AID-CNCR14>3.0.CO

[2]

2-W

[3] Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium:: Results of a randomized phase 2 trial [J].

Dogliotti, Luigi ;

Carteni, Giacomo ;

Siena, Salvatore ;

Bertetto, Oscar ;

Martoni, Andrea ;

Bono, Aldo ;

Amadori, Dino ;

Onat, Haluk ;

Marini, Luca .

EUROPEAN UROLOGY, 2007, 52 (01) :134-141

[4] Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urothelium - A trial of the eastern cooperative oncology group [J].

Dreicer, R ;

Manola, J ;

Roth, BJ ;

See, WA ;

Kuross, S ;

Edelman, MJ ;

Hudes, GR ;

Wilding, G .

CANCER, 2004, 100 (08) :1639-1645

[5]

Petrioli R, 1996, CANCER, V77, P344, DOI 10.1002/(SICI)1097-0142(19960115)77:2<344::AID-CNCR18>3.0.CO

[6]

2-1

[7] PRELIMINARY-RESULTS OF M-VAC (METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN) FOR TRANSITIONAL CELL-CARCINOMA OF THE UROTHELIUM [J].

STERNBERG, CN ;

YAGODA, A ;

SCHER, HI ;

WATSON, RC ;

AHMED, T ;

WEISELBERG, LR ;

GELLER, N ;

HOLLANDER, PS ;

HERR, HW ;

SOGANI, PC ;

MORSE, MJ ;

WHITMORE, WF .

JOURNAL OF UROLOGY, 1985, 133 (03) :403-407

[8] Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy amd recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors:: European organization for research and treatment of cancer protocol no. 30924 [J].

Sternberg, CN ;

de Mulder, PHM ;

Schornagel, JH ;

Théodore, C ;

Fossa, SD ;

van Oosterom, AT ;

Witjes, F ;

Spina, M ;

van Groeningen, CJ ;

de Balincourt, C ;

Collette, L .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) :2638-2646

[9]

von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757

[10] Randomized phase II trials: What does randomization gain? [J].

Wieand, HS .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) :1794-1795

← 1 →